Manufacturer record
Ronak Life Care Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Ronak Life Care Pvt. Ltd (Gujarat) were declared Not of Standard Quality between December 2019 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 41046, Levocetirizine Hydrochloride and Montelukast Tablets (exp Oct 2027). RDTL, Guwahati (CDSCO lab) found it not of standard quality: The sample does not comply as per I.P. 2022 with respect to the test for Dissolution of Montelukast. Listed in the August 2026 alert.
Records by type
3 records linked to Ronak Life Care Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Levocetirizine Hydrochloride and Montelukast Tablets | Batch 41046Mfg Nov 2025 · Exp Oct 2027 | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution of Montelukast.Dissolution | RDTL, GuwahatiCDSCO lab | Aug 2026 |
| Domperidone & Omeprazole Capsules (ROCID D CAPSULES) | Batch RC-010Mfg Jul 2019 · Exp May 2022 | DissolutionDissolution | RDTL GuwahatiState lab | Jul 2020 |
| Azithromycin Tablets I.P. 500 mg (Zolid 500) | Batch RAL-048Mfg Jun 2018 · Exp May 2020 | DissolutionDissolution | RDTL GuwahatiState lab | Dec 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.